(HEI) Heico - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4228061093
Stock: Jet Parts, Insulation, Avionics, Electro-Optics, RF Shielding
Total Rating 67
Risk 97
Buy Signal -0.03
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.08% |
| Yield on Cost 5y | 0.18% |
| Yield CAGR 5y | 7.85% |
| Payout Consistency | 90.4% |
| Payout Ratio | 3.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.0% |
| Relative Tail Risk | -3.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 26.22 |
| Character TTM | |
|---|---|
| Beta | 0.687 |
| Beta Downside | 0.580 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.26% |
| CAGR/Max DD | 1.12 |
Description: HEI Heico January 29, 2026
HEICO Corporation (NYSE:HEI) operates two primary businesses: the Flight Support Group, which supplies jet-engine and aircraft component replacement parts, thermal-insulation systems, and provides repair-overhaul services for both commercial and military aviation; and the Electronic Technologies Group, which designs and manufactures a broad portfolio of electro-optical, microwave, power-electronics, and RF-shielding products, including specialty semiconductors, traveling-wave tube amplifiers, and radiation-detection equipment.
In FY 2025 the company generated $2.03 billion in revenue, up 7% year-over-year, with an operating margin of 15.2% and free cash flow of $312 million, reflecting strong aftermarket demand. The aerospace aftermarket is buoyed by a 5% annual increase in U.S. defense spending and a resurgence in commercial aviation utilization, while the electronics segment benefits from rising RF-interference mitigation needs in 5G and satellite constellations.
For a deeper, data-driven valuation analysis, explore the detailed metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 690.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.05 > 1.0 |
| NWC/Revenue: 33.99% < 20% (prev 36.25%; Δ -2.26% < -1%) |
| CFO/TA 0.11 > 3% & CFO 934.3m > Net Income 690.4m |
| Net Debt (1.98b) to EBITDA (1.22b): 1.62 < 3 |
| Current Ratio: 2.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (141.1m) vs 12m ago 0.37% < -2% |
| Gross Margin: 41.09% > 18% (prev 0.42%; Δ 4067 % > 0.5%) |
| Asset Turnover: 55.74% > 50% (prev 50.81%; Δ 4.93% > 0%) |
| Interest Coverage Ratio: 7.88 > 6 (EBITDA TTM 1.22b / Interest Expense TTM 129.9m) |
Altman Z'' 4.36
| A: 0.18 (Total Current Assets 2.36b - Total Current Liabilities 832.0m) / Total Assets 8.50b |
| B: 0.43 (Retained Earnings 3.65b / Total Assets 8.50b) |
| C: 0.13 (EBIT TTM 1.02b / Avg Total Assets 8.05b) |
| D: 0.89 (Book Value of Equity 3.65b / Total Liabilities 4.12b) |
| Altman-Z'' Score: 4.36 = AA |
Beneish M -2.93
| DSRI: 1.00 (Receivables 756.9m/650.7m, Revenue 4.49b/3.86b) |
| GMI: 1.02 (GM 41.09% / 41.81%) |
| AQI: 0.98 (AQ_t 0.67 / AQ_t-1 0.68) |
| SGI: 1.16 (Revenue 4.49b / 3.86b) |
| TATA: -0.03 (NI 690.4m - CFO 934.3m) / TA 8.50b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
What is the price of HEI shares?
As of February 08, 2026, the stock is trading at USD 326.67 with a total of 406,062 shares traded.
Over the past week, the price has changed by -1.28%, over one month by -6.05%, over three months by +2.91% and over the past year by +40.66%.
Over the past week, the price has changed by -1.28%, over one month by -6.05%, over three months by +2.91% and over the past year by +40.66%.
Is HEI a buy, sell or hold?
Heico has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy HEI.
- StrongBuy: 9
- Buy: 4
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HEI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 373.6 | 14.4% |
| Analysts Target Price | 373.6 | 14.4% |
| ValueRay Target Price | 408.2 | 25% |
HEI Fundamental Data Overview February 07, 2026
P/E Trailing = 66.1807
P/E Forward = 58.4795
P/S = 10.0181
P/B = 10.4363
P/EG = 3.1831
Revenue TTM = 4.49b USD
EBIT TTM = 1.02b USD
EBITDA TTM = 1.22b USD
Long Term Debt = 2.16b USD (from longTermDebt, last quarter)
Short Term Debt = 29.1m USD (from shortTermDebt, last quarter)
Debt = 2.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 46.91b USD (44.93b + Debt 2.19b - CCE 217.8m)
Interest Coverage Ratio = 7.88 (Ebit TTM 1.02b / Interest Expense TTM 129.9m)
EV/FCF = 54.46x (Enterprise Value 46.91b / FCF TTM 861.4m)
FCF Yield = 1.84% (FCF TTM 861.4m / Enterprise Value 46.91b)
FCF Margin = 19.21% (FCF TTM 861.4m / Revenue TTM 4.49b)
Net Margin = 15.39% (Net Income TTM 690.4m / Revenue TTM 4.49b)
Gross Margin = 41.09% ((Revenue TTM 4.49b - Cost of Revenue TTM 2.64b) / Revenue TTM)
Gross Margin QoQ = 40.17% (prev 39.84%)
Tobins Q-Ratio = 5.52 (Enterprise Value 46.91b / Total Assets 8.50b)
Interest Expense / Debt = 1.50% (Interest Expense 32.9m / Debt 2.19b)
Taxrate = 18.03% (44.6m / 247.4m)
NOPAT = 838.9m (EBIT 1.02b * (1 - 18.03%))
Current Ratio = 2.83 (Total Current Assets 2.36b / Total Current Liabilities 832.0m)
Debt / Equity = 0.51 (Debt 2.19b / totalStockholderEquity, last quarter 4.31b)
Debt / EBITDA = 1.62 (Net Debt 1.98b / EBITDA 1.22b)
Debt / FCF = 2.29 (Net Debt 1.98b / FCF TTM 861.4m)
Total Stockholder Equity = 4.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.58% (Net Income 690.4m / Total Assets 8.50b)
RoE = 17.09% (Net Income TTM 690.4m / Total Stockholder Equity 4.04b)
RoCE = 16.49% (EBIT 1.02b / Capital Employed (Equity 4.04b + L.T.Debt 2.16b))
RoIC = 13.21% (NOPAT 838.9m / Invested Capital 6.35b)
WACC = 8.11% (E(44.93b)/V(47.13b) * Re(8.45%) + D(2.19b)/V(47.13b) * Rd(1.50%) * (1-Tc(0.18)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.46%
[DCF Debug] Terminal Value 80.89% ; FCFF base≈762.5m ; Y1≈940.6m ; Y5≈1.60b
Fair Price DCF = 444.0 (EV 26.46b - Net Debt 1.98b = Equity 24.48b / Shares 55.1m; r=8.11% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 31.03 | EPS CAGR: -44.00% | SUE: -2.99 | # QB: 0
Revenue Correlation: 97.62 | Revenue CAGR: 27.22% | SUE: 1.40 | # QB: 4
EPS next Quarter (2026-04-30): EPS=1.32 | Chg30d=+0.009 | Revisions Net=+2 | Analysts=15
EPS current Year (2026-10-31): EPS=5.57 | Chg30d=+0.007 | Revisions Net=+2 | Growth EPS=+13.6% | Growth Revenue=+11.5%
EPS next Year (2027-10-31): EPS=6.29 | Chg30d=+0.022 | Revisions Net=+3 | Growth EPS=+12.9% | Growth Revenue=+8.1%
P/E Forward = 58.4795
P/S = 10.0181
P/B = 10.4363
P/EG = 3.1831
Revenue TTM = 4.49b USD
EBIT TTM = 1.02b USD
EBITDA TTM = 1.22b USD
Long Term Debt = 2.16b USD (from longTermDebt, last quarter)
Short Term Debt = 29.1m USD (from shortTermDebt, last quarter)
Debt = 2.19b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.98b USD (from netDebt column, last quarter)
Enterprise Value = 46.91b USD (44.93b + Debt 2.19b - CCE 217.8m)
Interest Coverage Ratio = 7.88 (Ebit TTM 1.02b / Interest Expense TTM 129.9m)
EV/FCF = 54.46x (Enterprise Value 46.91b / FCF TTM 861.4m)
FCF Yield = 1.84% (FCF TTM 861.4m / Enterprise Value 46.91b)
FCF Margin = 19.21% (FCF TTM 861.4m / Revenue TTM 4.49b)
Net Margin = 15.39% (Net Income TTM 690.4m / Revenue TTM 4.49b)
Gross Margin = 41.09% ((Revenue TTM 4.49b - Cost of Revenue TTM 2.64b) / Revenue TTM)
Gross Margin QoQ = 40.17% (prev 39.84%)
Tobins Q-Ratio = 5.52 (Enterprise Value 46.91b / Total Assets 8.50b)
Interest Expense / Debt = 1.50% (Interest Expense 32.9m / Debt 2.19b)
Taxrate = 18.03% (44.6m / 247.4m)
NOPAT = 838.9m (EBIT 1.02b * (1 - 18.03%))
Current Ratio = 2.83 (Total Current Assets 2.36b / Total Current Liabilities 832.0m)
Debt / Equity = 0.51 (Debt 2.19b / totalStockholderEquity, last quarter 4.31b)
Debt / EBITDA = 1.62 (Net Debt 1.98b / EBITDA 1.22b)
Debt / FCF = 2.29 (Net Debt 1.98b / FCF TTM 861.4m)
Total Stockholder Equity = 4.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.58% (Net Income 690.4m / Total Assets 8.50b)
RoE = 17.09% (Net Income TTM 690.4m / Total Stockholder Equity 4.04b)
RoCE = 16.49% (EBIT 1.02b / Capital Employed (Equity 4.04b + L.T.Debt 2.16b))
RoIC = 13.21% (NOPAT 838.9m / Invested Capital 6.35b)
WACC = 8.11% (E(44.93b)/V(47.13b) * Re(8.45%) + D(2.19b)/V(47.13b) * Rd(1.50%) * (1-Tc(0.18)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.46%
[DCF Debug] Terminal Value 80.89% ; FCFF base≈762.5m ; Y1≈940.6m ; Y5≈1.60b
Fair Price DCF = 444.0 (EV 26.46b - Net Debt 1.98b = Equity 24.48b / Shares 55.1m; r=8.11% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 31.03 | EPS CAGR: -44.00% | SUE: -2.99 | # QB: 0
Revenue Correlation: 97.62 | Revenue CAGR: 27.22% | SUE: 1.40 | # QB: 4
EPS next Quarter (2026-04-30): EPS=1.32 | Chg30d=+0.009 | Revisions Net=+2 | Analysts=15
EPS current Year (2026-10-31): EPS=5.57 | Chg30d=+0.007 | Revisions Net=+2 | Growth EPS=+13.6% | Growth Revenue=+11.5%
EPS next Year (2027-10-31): EPS=6.29 | Chg30d=+0.022 | Revisions Net=+3 | Growth EPS=+12.9% | Growth Revenue=+8.1%